Oct 3 (Reuters) – Ultragenyx Pharmaceutical Inc : * ULTRAGENYX REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Alasdair Pal SYDNEY, July 6 (Reuters) - Australian Prime Minister Anthony Albanese apologised on…
By Alasdair Pal SYDNEY, July 6 (Reuters) - Australian Prime Minister Anthony Albanese apologised on…
By Rollo Ross NEW YORK, July 5 (Reuters) - Filmmaker Christopher Nolan follows up his…
By Rosalba O'Brien NEW YORK, July 5 (Reuters) - Watching the World Cup and hearing…
By Rollo Ross NEW YORK, July 5 (Reuters) - Filmmaker Christopher Nolan follows up his…
By Rosalba O'Brien NEW YORK, July 5 (Reuters) - Watching the World Cup and hearing…